Ilika plc signs MOU with Cirtec Medical

Ilika plc

Ilika Plc (LON:IKA), a pioneer in solid-state battery technology, has announced it has broadened its relationship with Cirtec Medical, an industry-leading strategic outsourcing partner of complex medical devices including minimally invasive and active implantable devices, by signing a memorandum of understanding which outlines the transfer of Stereax mm-scale battery manufacturing to Cirtec’s facility in Lowell, Massachusetts, U.S.

Ilika will focus on advanced technology development and IP licensing in support of Cirtec’s manufacturing and commercialisation activities. This partnership will reinforce Cirtec’s ongoing activities in system level miniaturisation for the medical device industry. Benefits of this partnership, to Ilika, include:

·    Further validation of Stereax’s capabilities

·    Manufacturing partnership delivering economy of scale and ability to rapidly ramp production

·    Expanded business development team bringing additional commercial momentum

In due course Ilika and Cirtec envisage signing a contract once the terms of the partnership have been finalised and a further announcement will be made at this time.

Graeme Purdy, Ilika Plc’s Chief Executive Officer, said: “Our partnership with Cirtec reinforces a pathway towards commercialisation of our Stereax battery technology. Cirtec brings a wealth of manufacturing experience and a strong track record of successful product commercialisation in the medical device industry.”

Brian Highley, Cirtec Medical Chief Executive Officer, commented: “With over 20 years of experience in the design, development and manufacturing of medical devices, Cirtec is uniquely poised to work with Ilika in bringing its Stereax battery technology to market. We believe this collaboration fits right into our strengths and expands upon our mission to vertically integrate our capabilities to support our offerings to the implantable and wearable device markets.”

Ilika specializes in the development of solid-state batteries. Its Stereax product line is designed for miniature medical implants and specialist internet of Things (IoT) applications. Stereax enables disruptive product designers looking for an intrinsically safe, long life (1000s recharges), low leakage (nA) and miniature power source in a rectangular form factor similar to ICs. 

We’ll keep you in the loop!

Join 1,000's of investors who read our articles first

We don’t spam! Read our privacy policy for more info.

Share on:
Find more news, interviews, share price & company profile here for:

Latest Company News

Ilika positions solid state batteries for the future of implantable neurostimulation

Ilika’s Stereax solid state battery technology supports the development of smaller, safer and more practical implantable neurostimulation devices for emerging medical applications.

Ilika advances manufacturing readiness for solid-state batteries

Ilika’s collaboration with UKBIC shows how manufacturing validation is helping move its Goliath pouch cell technology closer to commercial readiness.

Ilika reports first Stereax revenues and Goliath progress

Ilika expects FY26 revenue of approximately ÂŁ1.1m, including first commercial Stereax electrode sales, with Goliath evaluation activity expanding across automotive, defence and e-bike applications.

Defence battery demand highlights strategic opening for Ilika

Ilika highlights how rising defence and energy security demands are expanding the commercial opportunity for advanced battery technologies across military and infrastructure markets.

Ilika to showcase Stereax batteries to medical device manufacturers

Ilika’s Stereax batteries will be represented at Medical Technology Ireland 2026, giving the company direct exposure to medical device manufacturers and suppliers.

Search